Page 35 - BH-3-1
P. 35

Brain & Heart                                                                Cardioneuroablation for VMB



               vagus nerve during cardioneuroablation.  Heart Rhythm.   of cardiac denervation procedures: The anatomically guided
               2022;19(8):1247-1252.                              septal approach.  JACC Clin Electrophysiol.  2023;9(8):
                                                                  1344-1353.
               doi: 10.1016/j.hrthm.2022.04.014
                                                                  doi: 10.1016/j.jacep.2023.01.032
            28.  Wileczek A, Stodolkiewicz-Nowarska E, Reichert A,
               et al. Reevaluation of indications for permanent pacemaker   38.  Song ZL, Qin M, Liu X. Cardioneuroablation for the
               implantation after cardioneuroablation.  Kardiol Pol.   treatment of symptomatic bradycardia mediated by
               2023;81(12):1272-1275.                             the cardiac autonomic nervous.  J  Geriatr  Cardiol.
                                                                  2023;20(9):615-617.
               doi: 10.33963/v.kp.97828
                                                                  doi: 10.26599/1671-5411.2023.09.001
            29.  Choi NH, Hong J, Moak JP. Cardioneuroablation for
               pediatric patients with functional sinus node dysfunction   39.  Han Y, Shao M, Yang H, et al. Safety and efficacy of
               and  paroxysmal  atrioventricular  block.  J  Cardiovasc   cardioneuroablation for vagal bradycardia in a single arm
               Electrophysiol. 2024;35(2):221-229.                prospective study. Sci Rep. 2024;14(1):5926.
               doi: 10.1111/jce.16145                             doi: 10.1038/s41598-024-56651-9
            30.  Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred   40.  Aksu T, Güler TE, Bozyel S, Özcan KS, Yalın K, Mutluer FO.
               reporting items for systematic reviews and meta-analyses:   Cardioneuroablation in the treatment of neurally mediated
               The PRISMA statement. BMJ. 2009;339:b2535.         reflex  syncope:  A  review  of the  current literature.  Turk
                                                                  Kardiyol Dern Ars. 2017;45(1):33-41.
               doi: 10.1136/bmj.b2535
                                                                  doi: 10.5543/tkda.2016.55250
            31.  Stang A. Critical evaluation of the Newcastle-Ottawa scale
               for the assessment of the quality of nonrandomized studies   41.  Vandenberk B, Lei LY, Ballantyne B, et al. Cardioneuroablation
               in meta-analyses. Eur J Epidemiol. 2010;25(9):603-605.  for vasovagal syncope: A  systematic review and meta-
                                                                  analysis. Heart Rhythm. 2022;19(11):1804-1812.
               doi: 10.1007/s10654-010-9491-z
                                                                  doi: 10.1016/j.hrthm.2022.06.017
            32.  Güler TE, Aksu T. Long-term efficacy and safety of
               cardioneuroablation in patients with vagally mediated   42.  Hou Y, Scherlag BJ, Lin J, et al. Ganglionated plexi modulate
               bradyarrhythmias. J Updates Cardiovasc Med. 2020;8(1):28-34.  extrinsic cardiac autonomic nerve input: Effects on sinus rate,
                                                                  atrioventricular conduction, refractoriness, and inducibility
               doi: 10.32596/ejcm.galenos.2020.02.07
                                                                  of atrial fibrillation. J Am Coll Cardiol. 2007;50(1):61-68.
            33.  Lu CS, Guo CJ, Fang DP, Hao P, He DF, Xu AG. Initial
               experience with ablation of the innervation surrounding      doi: 10.1016/j.jacc.2007.02.066
               sinus and atrioventricular nodes to treat paroxysmal   43.  Hou Y, Scherlag BJ, Lin J,  et al. Interactive atrial neural
               bradyarrhythmia. Chin Med J (Engl). 2020;133(2):134-140.  network:  Determining  the  connections  between
                                                                  ganglionated plexi. Heart Rhythm. 2007;4(1):56-63.
               doi: 10.1097/CM9.0000000000000595
                                                                  doi: 10.1016/j.hrthm.2006.09.020
            34.  Aksu T, Guler TE, Bozyel S, et al. Medium-term results of
               cardioneuroablation for clinical bradyarrhythmias and   44.  Hou  Y,  Zhou Q,  Po  SS.  Neuromodulation  for cardiac
               vasovagal syncope: Effects on QT interval and heart rate.   arrhythmia. Heart Rhythm. 2016;13(2):584-592.
               J Interv Card Electrophysiol. 2021;60(1):57-68.
                                                                  doi: 10.1016/j.hrthm.2015.10.001
               doi: 10.1007/s10840-020-00704-2
                                                               45.  Pauza DH, Skripka V, Pauziene N, Stropus R. Morphology,
            35.  Mesquita D, Parreira L, Carmo P, et al. Anatomic guided   distribution, and variability of the epicardiac neural
               ablation of the atrial right ganglionated plexi is enough   ganglionated subplexuses in the human heart.  Anat Rec.
               for cardiac autonomic modulation in patients with   2000;259(4):353-382.
               significant bradyarrhythmias. Indian Pacing Electrophysiol J.      doi:  10.1002/1097-0185(20000801)259:4<353:AID-
               2021;21(6):327-334.
                                                                  AR10>3.0.CO;2-R
               doi: 10.1016/j.ipej.2021.07.002
                                                               46.  Aksu T, Guler TE, Yalin K, Bozyel S, Mutluer FO. A new
            36.  Chen W, Liu Z, Xiao P, et al. Extracardiac vagal stimulation-  and simple technique for vagal ganglia ablation in a patient
               assisted  cardioneuroablation:  Dynamically evaluating the   with functional atrioventricular block: Electroanatomical
               impact of sequential ganglionated plexus ablation on vagal   approach. Turk Kardiyol Dern Ars. 2018;46(6):494-500.
               control of SAN and AVN in patients with sinoatrial node      doi: 10.5543/tkda.2017.15163
               dysfunction. J Cardiovasc Dev Dis. 2022;9(6):188.
                                                               47.  Aksu T, Guler TE, Bozyel S, Yalin K. Vagal responses during
               doi: 10.3390/jcdd9060188
                                                                  cardioneuroablation on different ganglionated plexi: Is there
            37.  Rivarola EWR, Hachul D, Wu TC, et al. Long-term outcome   any role of ablation strategy? Int J Cardiol. 2019;304:50-55.


            Volume 3 Issue 1 (2025)                         10                               doi: 10.36922/bh.4824
   30   31   32   33   34   35   36   37   38   39   40